The United States announces that it will impose 100% tariffs on imported patented drugs and pharmaceutical ingredients

New York, April 2 (Xinhua) -- The White House announced on the 2nd that US President Trump signed a document that, in accordance with Section 232 of the 1962 Trade Expansion Act, will impose 100% tariffs on imported patented drugs and pharmaceutical ingredients. This measure also provides a pathway for exemptions or tariff reductions, aimed at forcing pharmaceutical companies to reach agreements with the White House on drug prices and industry return.